Cardiovascular risk factors in patients with HIV infection.
Keywords:
ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE, ACQUIRED IMMUNODEFICIENCY SYNDROME, CHRONIC DISEASE, LIPID METABOLISM DISORDERS, INSULIN RESISTANCE, ATHEROSCLEROSIS, CARDIOVASCULAR DISEASES, CEREBROVASCULAR DISORDERS, COUNTRIES, HUMANSAbstract
After the introduction of the antiretroviral treatment, AIDS has become a chronic disease in developed countries. Cardiovascular risk seems to be a little bigger in HIV patients than in non-infected ones. After introducing antiretroviral therapy, several metabolic disturbances have been observed, related mainly with the lipid profile and insulin resistance. It is due to the same HIV, the antiretroviral therapy and a high prevalence of classical risk facts. Several evidence traces suggest that atherosclerosis may be more frequent or may develop faster in HIV+ individuals, especially in those treated with potent antiretroviral combinations. This new necessity of affronting cardiovascular risk as part of HIV patients care highlights the importance of treating the patient in a global form.Downloads
Published
How to Cite
Issue
Section
License
All content published in this journal is Open Access, distributed under the terms of the CC BY-NC 4.0 License.
It allows:
- Copy and redistribute published material in any medium or format.
- Adapt the content.
This will be done under the following terms:
- Attribute the authors' credits and indicate whether changes were made, in which case it must be in a reasonable way.
- Non-commercial use.
- Recognize the journal where it is published.
The copyrights of each article are maintained, without restrictions.

